MacuLogix's Series B Round

MacuLogix raised a round of funding on June 05, 2014.

MacuLogix is a provider in the early detection and tracking of age-related macular degeneration (AMD). MacuLogix' AdaptDx has received FDA 510(k) clearance for measurement of dark adaptation function …

Articles about MacuLogix's Series B Round: